Yaacov Herzig

916 total citations
9 papers, 568 citations indexed

About

Yaacov Herzig is a scholar working on Molecular Biology, Neurology and Organic Chemistry. According to data from OpenAlex, Yaacov Herzig has authored 9 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Neurology and 2 papers in Organic Chemistry. Recurrent topics in Yaacov Herzig's work include Parkinson's Disease Mechanisms and Treatments (3 papers), Biochemical and Molecular Research (3 papers) and Epilepsy research and treatment (2 papers). Yaacov Herzig is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (3 papers), Biochemical and Molecular Research (3 papers) and Epilepsy research and treatment (2 papers). Yaacov Herzig collaborates with scholars based in Israel, Italy and United States. Yaacov Herzig's co-authors include Jeffrey Sterling, František Hubálek, Dale E. Edmondson, Andrea Mattevi, Claudia Binda, Min Li, Roger Rahmani, Itzhak Ofek, Eric Rubinstein and Min Li and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and The Journal of Organic Chemistry.

In The Last Decade

Yaacov Herzig

9 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaacov Herzig Israel 7 209 179 170 99 67 9 568
Pierre C. Wyss Switzerland 9 207 1.0× 168 0.9× 61 0.4× 52 0.5× 60 0.9× 16 393
Lesetja J. Legoabe South Africa 19 338 1.6× 601 3.4× 291 1.7× 73 0.7× 52 0.8× 79 1.1k
Fernando Durães Portugal 10 195 0.9× 176 1.0× 144 0.8× 23 0.2× 47 0.7× 23 555
Jong‐Hyun Park South Korea 15 291 1.4× 228 1.3× 161 0.9× 90 0.9× 79 1.2× 39 752
Agnieszka Olejarz‐Maciej Poland 15 257 1.2× 179 1.0× 99 0.6× 20 0.2× 86 1.3× 34 515
Wenxin Gu United States 15 616 2.9× 246 1.4× 154 0.9× 22 0.2× 30 0.4× 39 940
Agostino Bruno Italy 18 453 2.2× 154 0.9× 73 0.4× 15 0.2× 118 1.8× 35 715
Livia Basile Italy 16 316 1.5× 210 1.2× 145 0.9× 8 0.1× 33 0.5× 47 697
Manuela Grimaldi Italy 17 342 1.6× 84 0.5× 86 0.5× 22 0.2× 33 0.5× 54 686
Francesco Attanasio Italy 19 354 1.7× 119 0.7× 79 0.5× 18 0.2× 39 0.6× 48 782

Countries citing papers authored by Yaacov Herzig

Since Specialization
Citations

This map shows the geographic impact of Yaacov Herzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaacov Herzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaacov Herzig more than expected).

Fields of papers citing papers by Yaacov Herzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaacov Herzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaacov Herzig. The network helps show where Yaacov Herzig may publish in the future.

Co-authorship network of co-authors of Yaacov Herzig

This figure shows the co-authorship network connecting the top 25 collaborators of Yaacov Herzig. A scholar is included among the top collaborators of Yaacov Herzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaacov Herzig. Yaacov Herzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ashani, Yacov, et al.. (2007). The Kinetics of Inhibition of Human Acetylcholinesterase and Butyrylcholinesterase by Two Series of Novel Carbamates. Molecular Pharmacology. 71(6). 1610–1617. 59 indexed citations
2.
Falb, Eliezer, et al.. (2006). Novel 5-Dimethylamino-1- and 2-Indanyl Uracil Derivatives. The Journal of Organic Chemistry. 71(18). 7053–7056. 5 indexed citations
3.
Herzig, Yaacov, et al.. (2006). Hydroxy-1-aminoindans and Derivatives:  Preparation, Stability, and Reactivity. The Journal of Organic Chemistry. 71(11). 4130–4140. 22 indexed citations
4.
Binda, Claudia, František Hubálek, Min Li, et al.. (2005). Binding of Rasagiline-Related Inhibitors to Human Monoamine Oxidases:  A Kinetic and Crystallographic Analysis. Journal of Medicinal Chemistry. 48(26). 8148–8154. 90 indexed citations
5.
Binda, Claudia, František Hubálek, Min Li, et al.. (2004). Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of theN-Propargylaminoindan Class. Journal of Medicinal Chemistry. 47(7). 1767–1774. 186 indexed citations
6.
Hubálek, František, Claudia Binda, Min Li, et al.. (2004). Inactivation of Purified Human Recombinant Monoamine Oxidases A and B by Rasagiline and Its Analogues. Journal of Medicinal Chemistry. 47(7). 1760–1766. 83 indexed citations
7.
Bialer, Meir, et al.. (1996). PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF (E)-2-ENE VALPROYL DERIVATIVES OF GLYCINE AND VALPROYL DERIVATIVES OF NIPECOTIC ACID. Biopharmaceutics & Drug Disposition. 17(7). 565–575. 6 indexed citations
8.
Bialer, Meir, Salim Hadad, Bassam Kadry, et al.. (1996). Pharmacokinetic Analysis and Antiepileptic Activity of Tetra-Methylcyclopropane Analogues of Valpromide. Pharmaceutical Research. 13(2). 284–289. 23 indexed citations
9.
Ofek, Itzhak, et al.. (1994). Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. Antimicrobial Agents and Chemotherapy. 38(2). 374–377. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026